<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101298744</journal-id><journal-id journal-id-type="pubmed-jr-id">34538</journal-id><journal-id journal-id-type="nlm-ta">Retin Cases Brief Rep</journal-id><journal-id journal-id-type="iso-abbrev">Retin Cases Brief Rep</journal-id><journal-title-group><journal-title>Retinal cases &#x00026; brief reports</journal-title></journal-title-group><issn pub-type="ppub">1935-1089</issn><issn pub-type="epub">1937-1578</issn></journal-meta><article-meta><article-id pub-id-type="pmid">26650564</article-id><article-id pub-id-type="pmc">4899314</article-id><article-id pub-id-type="doi">10.1097/ICB.0000000000000254</article-id><article-id pub-id-type="manuscript">NIHMS732042</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Severe Panuveitis, Retinal Vasculitis, and Optic Disc Granuloma Secondary to Sarcoidosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Patterson</surname><given-names>Michael</given-names></name><degrees>DO</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bergstrom</surname><given-names>Chris S.</given-names></name><degrees>MD/OD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Clark</surname><given-names>W. Lloyd</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Grossniklaus</surname><given-names>Hans E.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Payne</surname><given-names>John F.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Ophthalmology, University of South Carolina, Columbia, SC</aff><aff id="A2"><label>2</label>Department of Ophthalmology, Emory Eye Center, Atlanta, GA</aff><aff id="A3"><label>3</label>Palmetto Retina Center, West Columbia, SC</aff><author-notes><corresp id="FN1">Corresponding author and reprint requests to: John F. Payne, MD, Palmetto Retina Center, 124 Sunset Court, West Columbia, SC 29169, Phone: (803) 931-0077, Fax: (803) 931-0076, <email>jpayne@palmettoretina.com</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>24</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="ppub"><season>Fall</season><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>10</month><year>2017</year></pub-date><volume>10</volume><issue>4</issue><fpage>341</fpage><lpage>344</lpage><!--elocation-id from pubmed: 10.1097/ICB.0000000000000254--><abstract><sec id="S1"><title>Purpose</title><p id="P1">To report a case of panuveitis, retinal vasculitis, and optic disc granuloma due to sarcoidosis.</p></sec><sec id="S2"><title>Methods</title><p id="P2">Case report and literature review.</p></sec><sec id="S3"><title>Results</title><p id="P3">A 26 year-old previously healthy African American male presented with four months of gradual progressive visual decline in the right eye. Clinical examination revealed severe panuveitis, retinal vasculitis, and large optic nerve mass lesion. Diffuse supraclavicular lymphadenopathy was also present. Histopathologic examination of the lymph node biopsy revealed granulomatous inflammation with some areas of casseous necrosis, consistent with sarcoidosis.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Sarcoidosis is a common cause of uveitis and retinal vasculitis. In rare cases, an optic disc granuloma may occur and can be treated with immunosuppressive therapy.</p></sec></abstract><kwd-group><kwd>Optic Disc Granuloma</kwd><kwd>Retinal Vasculitis</kwd><kwd>Sarcoidosis</kwd><kwd>Uveitis</kwd></kwd-group></article-meta></front><body><p id="P5">Sarcoidosis is an idiopathic, multisystem granulomatous disorder with ocular involvement occurring in 25&#x02013;60% of cases.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The histopathologic hallmark of the disease is noncaseating granuloma formation.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> Clinically, optic nerve involvement can present as papilledema, papillitis, and/or granulomatous infiltration of the optic disc.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup> We report a case of sarcoidosis which presented with panuveitis, retinal vasculitis, and optic nerve granuloma.</p><sec id="S5"><title>Case Report</title><p id="P6">A 26 year-old previously healthy African-American male presented with four months of painless vision loss in the right eye. Review of systems was positive for floaters and progressive lymphadenopathy. Visual acuity was hand motions right eye and 20/25 left eye. A relative afferent pupillary defect was present in the right eye, and there was marked bilateral submandibular and supraclavicular lymphadenopathy. Slit lamp biomicroscopy of the right eye showed trace anterior segment inflammation and a large vascularized optic disc granuloma (<xref rid="F1" ref-type="fig">Figure 1</xref>). There was also a peripapillary exudative retinal detachment, diffuse vascular sheathing, and a mid-peripheral choroidal granuloma. Ultrasonography revealed a 6.6 mm elevated optic nerve mass with low internal reflectivity. The left eye contained one focal area of vasculitis, and mild late disc leakage on fluorescein angiography.</p><p id="P7">The patient was admitted for further evaluation and lymph node biopsy. Angiotensin-converting enzyme and lysozyme levels were markedly elevated, while Quantiferon testing for tuberculosis was negative. Additional serologic testing for syphilis, human immunodeficiency virus, toxoplasmosis, and fungemia were negative. Chest computed tomography demonstrated bilateral hilar lymphadenopathy and diffuse nodular densities. Cervical lymph node biopsy revealed granulomatous inflammation with some areas of casseous necrosis (<xref rid="F2" ref-type="fig">Figure 2</xref>). Acid-fast bacilli and gomori methenamine silver stains were negative for tuberculosis and fungus, respectively, and flow cytometry showed no immunophenotypic evidence of lymphoma.</p><p id="P8">The patient&#x02019;s clinical presentation as well as radiographic and histopathologic examinations were consistent with advanced sarcoidosis and he was started on intravenous corticosteroids. He was transitioned to a slow oral prednisone taper, and because of the severity and extent of his disease, he was started on subcutaneous adalimumab therapy. There was significant improvement in the lymphadenopathy and subjective visual improvement within the first few weeks of treatment. At 21 months follow-up, his vision remained hand motions, but the optic nerve granuloma had decreased to 2.2 mm in thickness (<xref rid="F3" ref-type="fig">Figure 3</xref>). The left eye remained 20/20 and showed no signs of clinical activity.</p></sec><sec sec-type="discussion" id="S6"><title>Discussion</title><p id="P9">Sarcoidosis is most frequently a multisystem granulomatous disorder thought to result from an exaggerated immune response to a variety of antigens.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The exact pathogenesis remains unclear. The disease most often affects the lungs and thoracic lymph nodes, skin, and eyes, with anterior and posterior uveitis being the most frequent ocular manifestations.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The diagnosis remains one of exclusion and is based on clinical, radiographic, and histopathologic findings.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Radiographic testing typically reveals hilar lymphadenopathy and is often associated with elevated angiotensin-converting enzyme and lysozyme levels, all of which were present in our patient.<sup><xref rid="R1" ref-type="bibr">1</xref></sup></p><p id="P10">This patient&#x02019;s lymph node biopsy revealed tightly formed granulomas with some areas of casseous necrosis. While noncaseating granulomas are the hallmark histopathologic finding in sarcoidosis, Mitchell and colleagues and others reported that minor degrees of caseous necrosis can still be compatible with the diagnosis.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Although many of the clinical and histopathologic findings in sarcoidosis resemble those in patients with infectious diseases, no pathogenic organism has been implicated in its cause. In this case, our patient demonstrated negative serology and histopathology for syphilis, tuberculosis, toxoplasmosis, bartonella, cryptococcus, histoplasmosis and human immunodeficiency virus.</p><p id="P11"><xref rid="T1" ref-type="table">Table 1</xref> illustrates the nine reported cases of optic disc granuloma secondary to sarcoidosis since 1980. Our patient was slightly younger than the average age of these patients, which was 35 years. Almost all patients were African American and all had unilateral optic disc granulomas. Our patient appears to have the largest granuloma of those reported. The presenting visual acuity varied among the patients with four eyes having &#x02265; 20/30 vision and four eyes having &#x02264; 20/200 vision. Oral and/or intravenous corticosteroids were the initial treatment of choice and visual outcomes were mixed.</p><p id="P12">The list of differential diagnoses for a mass lesion on or around the optic nerve head in the setting of uveitis is relatively broad. Neoplastic, inflammatory, and vascular lesions are among the most common etiologies. Specific diseases include peripapillary choroidal hemangiomas or metastasis, amelanotic choroidal melanomas, sarcoid or tuberculous granulomas, and possibly Blau syndrome. Blau syndrome is a rare, autosomal dominant condition typically characterized by early-onset granulomatous arthritis, uveitis and skin lesions.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> While optic disc granulomas have not been specifically described in this condition, the granulomatous uveitis can be severe and multifocal choroiditis has been reported.<sup><xref rid="R12" ref-type="bibr">12</xref></sup></p><p id="P13">Central nervous system involvement has been estimated to occur in 5&#x02013;12% of all cases of sarcoidosis.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> Optic neuritis, myelopathy, and facial nerve palsy are among the most common presentations of those with neurosarcoidosis.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> The prognosis is variable but particularly poor when the optic nerve is involved.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> The development of an optic disc granuloma is exceedingly rare. Farr reported a case of acute vision loss secondary to a sarcoid optic disc granuloma and good visual recovery with oral corticosteroid use.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Our patient responded to immunosuppressive therapy but suffered significant vision loss because of the severity and chronicity of disease at presentation.</p></sec><sec sec-type="supplementary-material" id="S8"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>CLEAN version of revised manuscript</label><media xlink:href="NIHMS732042-supplement-CLEAN_version_of_revised_manuscript.docx" orientation="portrait" xlink:type="simple" id="d37e264" position="anchor"/></supplementary-material></sec></body><back><fn-group><fn id="FN2" fn-type="presented-at"><p>The information contained in this manuscript was presented at the 2013 annual meeting of The Retina Society in Beverly Hills, CA.</p></fn><fn fn-type="COI-statement" id="FN3"><p>None of the authors have any financial or proprietary interest in any material mentioned in this manuscript.</p></fn><fn id="FN4"><p>All of the authors had full access to the data in this study. The first author and corresponding author take responsibility for the integrity of the data and the accuracy of the data analysis.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umur</surname><given-names>KA</given-names></name><name><surname>Tayfun</surname><given-names>B</given-names></name><name><surname>Oguzhan</surname><given-names>O</given-names></name></person-group><article-title>Different ophthalmologic manifestations of sarcoidosis</article-title><source>Curr Opin Ophthalmol</source><year>2012</year><volume>23</volume><fpage>477</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">23014267</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaum</surname><given-names>AD</given-names></name><name><surname>Oh</surname><given-names>FS</given-names></name><name><surname>Chakrabarti</surname><given-names>A</given-names></name><name><surname>Tessler</surname><given-names>HH</given-names></name><name><surname>Goldstein</surname><given-names>DA</given-names></name></person-group><article-title>Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis</article-title><source>Arch Ophthalmol</source><year>2011</year><volume>129</volume><issue>4</issue><fpage>409</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">21482866</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>DN</given-names></name><name><surname>Scadding</surname><given-names>JG</given-names></name><name><surname>Heard</surname><given-names>BE</given-names></name><name><surname>Hinson</surname><given-names>KF</given-names></name></person-group><article-title>Sarcoidosis: histopathological definition and clinical diagnosis</article-title><source>J Clin Pathol</source><year>1977</year><volume>30</volume><issue>5</issue><fpage>395</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">325017</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>JM</given-names></name><name><surname>Bruno</surname><given-names>MK</given-names></name><name><surname>Winterkorn</surname><given-names>JMS</given-names></name><name><surname>Nealon</surname><given-names>N</given-names></name></person-group><article-title>The Pathogenesis and Treatment of Optic Disc Swelling in Neurosarcoidosis</article-title><source>Arch Neurol</source><year>2003</year><volume>60</volume><fpage>426</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">12633155</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farr</surname><given-names>AK</given-names></name><name><surname>Jabs</surname><given-names>DA</given-names></name><name><surname>Green</surname><given-names>WR</given-names></name></person-group><article-title>Optic disc sarcoid granuloma</article-title><source>Arch Ophthalmol</source><year>2000</year><volume>118</volume><issue>5</issue><fpage>728</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10815174</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustgarten</surname><given-names>JS</given-names></name><name><surname>Mindel</surname><given-names>JS</given-names></name><name><surname>Yablonski</surname><given-names>ME</given-names></name><name><surname>Friedman</surname><given-names>AH</given-names></name></person-group><article-title>An unusual presentation of isolated optic nerve sarcoidosis</article-title><source>J Clin Neuroophthalmol</source><year>1983</year><volume>3</volume><issue>1</issue><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">6222071</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>EM</given-names></name><name><surname>Ellis</surname><given-names>CJ</given-names></name><name><surname>Sanders</surname><given-names>MD</given-names></name><name><surname>McDonald</surname><given-names>WI</given-names></name></person-group><article-title>Optic neuropathy in sarcoidosis</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1986</year><volume>49</volume><issue>7</issue><fpage>756</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">3746306</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asensio Sanchez</surname><given-names>VM</given-names></name><name><surname>Corral Azor</surname><given-names>A</given-names></name><name><surname>Bartolome Aragon</surname><given-names>A</given-names></name><name><surname>De Paz Garcia</surname><given-names>M</given-names></name></person-group><article-title>Sarcoidosis of the optic nerve</article-title><source>Arch Soc Esp Oftalmol</source><year>2003</year><volume>78</volume><issue>3</issue><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">12677494</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frohman</surname><given-names>LP</given-names></name><name><surname>Guirgis</surname><given-names>M</given-names></name><name><surname>Turbin</surname><given-names>RE</given-names></name><name><surname>Bielory</surname><given-names>L</given-names></name></person-group><article-title>Sarcoidosis of the anterior visual pathway: 24 new cases</article-title><source>J Neuroophthalmol</source><year>2003</year><volume>23</volume><issue>3</issue><fpage>190</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">14504590</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koczman</surname><given-names>JJ</given-names></name><name><surname>Rouleau</surname><given-names>J</given-names></name><name><surname>Gaunt</surname><given-names>M</given-names></name><etal/></person-group><article-title>Neuro-ophthalmic sarcoidosis: the University of Iowa experience</article-title><source>Semin Ophthalmol</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">18432542</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschos</surname><given-names>MM</given-names></name><name><surname>Guex-Crosier</surname><given-names>Y</given-names></name></person-group><article-title>Anterior segment granuloma and optic nerve involvement as the presenting signs of systemic sarcoidosis</article-title><source>Clin Ophthalmol</source><year>2008</year><volume>2</volume><issue>4</issue><fpage>951</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">19668451</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>T</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name></person-group><article-title>Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation</article-title><source>Ophthalmology</source><year>2003</year><volume>110</volume><issue>10</issue><fpage>2040</fpage><lpage>2044</lpage><pub-id pub-id-type="pmid">14522785</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawate</surname><given-names>S</given-names></name><name><surname>Moses</surname><given-names>H</given-names></name><name><surname>Sriram</surname><given-names>S</given-names></name></person-group><article-title>Presentations and outcomes of neurosarcoidosis: a study of 54 cases</article-title><source>QJM</source><year>2009</year><volume>102</volume><issue>7</issue><fpage>449</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">19383611</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Montage fundus photograph of the right eye showing a very large vascularized optic disc granuloma with peripapillary exudative retinal detachment, and diffuse vasculitis. A mid-peripheral choroidal granuloma is visible in the inferotemporal quadrant.</p></caption><graphic xlink:href="nihms732042f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Histopathologic examination reveals granulomatous inflammation including palisading epithelioid histocytes (arrowhead) and giant cells (*) surrounding an area of casseous necrosis (arrow). (Hematoxalin-eosin, original magnification 10x)</p></caption><graphic xlink:href="nihms732042f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Color fundus photograph of the right eye 21 months after presentation. The optic disc margins are partially visible and the granuloma is much smaller in size. There is extensive prepapillary and subretinal fibrosis and diffuse sclerosis of the retinal vessels.</p></caption><graphic xlink:href="nihms732042f3"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p>Clinical characteristics and visual outcomes in patients with optic disc granuloma secondary to sarcoidosis since 1980.</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Publication</th><th valign="top" align="center" rowspan="1" colspan="1">Age/Sex (Years)</th><th valign="top" align="center" rowspan="1" colspan="1">Race</th><th valign="top" align="center" rowspan="1" colspan="1">Laterality of Granuloma</th><th valign="top" align="center" rowspan="1" colspan="1">Initial VA</th><th valign="top" align="center" rowspan="1" colspan="1">Treatment/Clinical Course</th><th valign="top" align="center" rowspan="1" colspan="1">Length of Follow-up</th><th valign="top" align="center" rowspan="1" colspan="1">VA at Last Follow-up</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">Lustgarten<sup><xref rid="R6" ref-type="bibr">6</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">32/Female</td><td align="center" valign="top" rowspan="1" colspan="1">African American</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/30</td><td align="center" valign="top" rowspan="1" colspan="1">Vision declined over several weeks to 20/200, unresponsive to oral corticosteroids. Sudden vision loss to NLP several weeks later due to optic disc granuloma.</td><td align="center" valign="top" rowspan="1" colspan="1">13 months</td><td align="center" valign="top" rowspan="1" colspan="1">NLP</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Graham<sup><xref rid="R7" ref-type="bibr">7</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">43/Female</td><td align="center" valign="top" rowspan="1" colspan="1">West Indian</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">NLP</td><td align="center" valign="top" rowspan="1" colspan="1">Oral corticosteroids failed to improve vision</td><td align="center" valign="top" rowspan="1" colspan="1">2 years</td><td align="center" valign="top" rowspan="1" colspan="1">NLP</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Farr<sup><xref rid="R5" ref-type="bibr">5</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">31/Female</td><td align="center" valign="top" rowspan="1" colspan="1">African American</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/25</td><td align="center" valign="top" rowspan="1" colspan="1">2 months after presentation, vision declined to 20/400. Oral corticosteroids started with 6 month taper</td><td align="center" valign="top" rowspan="1" colspan="1">18 months</td><td align="center" valign="top" rowspan="1" colspan="1">20/25</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Asensio Sanchez<sup><xref rid="R8" ref-type="bibr">8</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">59/Male</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/200</td><td align="center" valign="top" rowspan="1" colspan="1">Oral corticosteroids started</td><td align="center" valign="top" rowspan="1" colspan="1">1 year</td><td align="center" valign="top" rowspan="1" colspan="1">20/20</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Frohman<sup><xref rid="R9" ref-type="bibr">9</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">50/Female</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">NLP</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Frohman<sup><xref rid="R9" ref-type="bibr">9</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">32/Female</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/70</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Koczman<sup><xref rid="R10" ref-type="bibr">10</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">24/Male</td><td align="center" valign="top" rowspan="1" colspan="1">African American</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/25</td><td align="center" valign="top" rowspan="1" colspan="1">Oral/IV corticosteroids and methotrexate</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">20/15</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Moschos<sup><xref rid="R11" ref-type="bibr">11</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">19/Male</td><td align="center" valign="top" rowspan="1" colspan="1">African American</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Left eye)</td><td align="center" valign="top" rowspan="1" colspan="1">20/25</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td><td align="center" valign="top" rowspan="1" colspan="1">Not reported</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Current Study</td><td align="center" valign="top" rowspan="1" colspan="1">26/Male</td><td align="center" valign="top" rowspan="1" colspan="1">African American</td><td align="center" valign="top" rowspan="1" colspan="1">Unilateral (Right eye)</td><td align="center" valign="top" rowspan="1" colspan="1">HM</td><td align="center" valign="top" rowspan="1" colspan="1">IV corticosteroids followed by slow oral corticosteroid taper and adalimumab</td><td align="center" valign="top" rowspan="1" colspan="1">22 months</td><td align="center" valign="top" rowspan="1" colspan="1">HM</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>HM: Hand motions; IV: Intravenous; NLP: No light perception; VA: Visual acuity</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Summary Statement</title></caption><p id="P14">The patient presented with profound painless vision loss in the right eye and was found to have severe panuveitis, retinal vasculitis and optic disc granuloma due to sarcoidosis. The disease was managed with immunosuppressive therapy consisting of corticosteroids and adalimumab.</p></boxed-text></floats-group></article>